SG Americas Securities LLC Has $1.07 Million Stock Holdings in Azenta, Inc. (NASDAQ:AZTA)

SG Americas Securities LLC increased its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 90.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,972 shares of the company's stock after purchasing an additional 14,719 shares during the quarter. SG Americas Securities LLC owned approximately 0.07% of Azenta worth $1,073,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its holdings in Azenta by 0.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,033,171 shares of the company's stock worth $151,659,000 after buying an additional 26,929 shares during the last quarter. Schroder Investment Management Group boosted its holdings in Azenta by 46.7% during the fourth quarter. Schroder Investment Management Group now owns 1,405,056 shares of the company's stock worth $70,183,000 after buying an additional 447,292 shares during the last quarter. Lord Abbett & CO. LLC bought a new position in Azenta during the fourth quarter worth about $47,350,000. Federated Hermes Inc. boosted its holdings in Azenta by 65.9% during the fourth quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock worth $38,109,000 after buying an additional 302,786 shares during the last quarter. Finally, Royce & Associates LP boosted its holdings in Azenta by 2.4% during the fourth quarter. Royce & Associates LP now owns 758,068 shares of the company's stock worth $37,903,000 after buying an additional 18,091 shares during the last quarter. Institutional investors own 99.08% of the company's stock.

Azenta Trading Down 1.0%

Shares of NASDAQ:AZTA traded down $0.30 during trading on Friday, hitting $29.64. 901,287 shares of the company's stock traded hands, compared to its average volume of 701,189. Azenta, Inc. has a 52 week low of $23.91 and a 52 week high of $63.58. The company has a market cap of $1.36 billion, a price-to-earnings ratio of -21.32 and a beta of 1.62. The company has a 50-day moving average price of $27.53 and a 200-day moving average price of $38.73.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. During the same period in the prior year, the firm posted $0.06 EPS. The company's revenue was up 5.1% compared to the same quarter last year. On average, analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on AZTA. Needham & Company LLC reduced their target price on Azenta from $59.00 to $40.00 and set a "buy" rating on the stock in a report on Wednesday, May 7th. TD Cowen upgraded Azenta to a "hold" rating in a report on Thursday, February 27th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.